Scale-up of magnesium sulfate for treatment of pre-eclampsia and eclampsia in Nigeria

Pre-eclampsia/eclampsia is a serious condition that complicates 5% –10% of pregnancies globally [1] and, together with other hypertensive diseases of pregnancy, is responsible for approximately 14% of maternal deaths every year [2]. Because treatment requires early and careful monitoring of the pregnancy, the negative impact of these diseases is felt more in low- income countries where health-system factors often cause delay in reaching appropriate care [3]. In Nigeria, which has the second highest number of maternal deaths in the world [4], the prevalence of eclampsia/pre-eclampsia is reported at 163 per 10000 deliveries [5].
Source: International Journal of Gynaecology and Obstetrics - Category: OBGYN Authors: Tags: Special Communication Source Type: research